Apple Inc. said its hypertension detection system for its smart watch will arrive next week after receiving clearance Thursday from the U.S. Food and Drug Administration.

The feature, which was announced at Apple’s most recent product launch event in early September, will be available in 150 countries and regions, including the U.S., Hong Kong and the European Union. The company previously said it was waiting for approval from the FDA and other regulators.

The tool will use data from the Apple Watch’s optical heart sensor to analyze how a user’s blood vessels respond to heartbeats over a 30-day time period, according to Apple. The user will be notified if any signs of chronic hypertension, or high blood pressure, are detected and encouraged to share results with a medical provider.

The

See Full Page